Jayson Rieger has bought VRCA on 2 days since Nov 2025
CEO and President at Verrica Pharmaceuticals Inc.
SEC CIK 0002043558 · Filings on SEC.gov ↗
Jayson Rieger's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
2 filings since Nov 2025, newest first
About Jayson Rieger
Jayson Rieger, Ph.D., M.B.A. is the President and Chief Executive Officer of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), a dermatology therapeutics company, a role he assumed on November 5, 2024, while also serving on the board of directors.( Previously a director on Verrica's board from 2015 to 2018, Rieger brings over 20 years of experience in life sciences leadership, including business development, operations, drug discovery, and product development.(
Dr. Rieger, age 49, most recently served as Executive Vice President at PBM Capital from March 2014 to November 2024, followed by a consulting role, and continues as a managing partner there.( His prior positions include Corporate SVP and President of the Human Therapeutics Division at Intrexon Corporation (2012–2013), VP of Research and Virginia Operations at Clinical Data, Inc. (2008–2011), and VP of Lead Development at Adenosine Therapeutics, LLC (2002–2008).( He holds a B.A. in Chemistry from Rollins College, a Ph.D. in Medicinal Chemistry, and an M.B.A. from the University of Virginia.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.